Literature DB >> 7817920

Recovery of left ventricular function in acute nonischemic congestive cardiomyopathy.

A M Cross1, C Steenbergen, M B Higginbotham.   

Abstract

The extent and time course of recovery of left ventricular function were investigated in 29 patients with no previous symptoms who had acute nonischemic congestive cardiomyopathy and left ventricular ejection fraction of 0.22 +/- 0.07. Improvement in left ventricular ejection fraction by at least 0.05 was observed in 24 of the 29 patients and was achieved within 6 months after the initial evaluation. Progressive improvement was seen, with a maximum ejection fraction of 0.45 +/- 0.17 being achieved within approximately 18 months. The degree of ejection fraction recovery was not related to the initial clinical or hemodynamic variables. However, the extent of fibrosis detected on endomyocardial biopsy correlated inversely with subsequent changes in ejection fraction (r = -0.65, p = 0.0003). Thus significant recovery is likely after an acute episode of nonischemic cardiomyopathy and may be progressive during the first year. Recovery is related to the extent of myocardial fibrosis detected on endomyocardial biopsy but cannot be predicted from the initial clinical or hemodynamic presentation.

Entities:  

Mesh:

Year:  1995        PMID: 7817920     DOI: 10.1016/0002-8703(95)90038-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Yuichiro Iida; Miwa Iwamoto-Ishida; Takeru Nabeta; Shunsuke Ishii; Takanori Sato; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Mototsugu Nishii; Junya Ako
Journal:  Heart Vessels       Date:  2015-02-17       Impact factor: 2.037

2.  Low dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyopathy.

Authors:  H Kitaoka; J Takata; T Yabe; N Hitomi; T Furuno; Y L Doi
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

3.  A Development of Nucleic Chromatin Measurements as a New Prognostic Marker for Severe Chronic Heart Failure.

Authors:  Machiko Kanzaki; Yoshihiro Asano; Hatsue Ishibashi-Ueda; Eiji Oiki; Tomoki Nishida; Hiroshi Asanuma; Hisakazu Kato; Toru Oka; Tomohito Ohtani; Osamu Tsukamoto; Shuichiro Higo; Hidetaka Kioka; Ken Matsuoka; Yoshiki Sawa; Issei Komuro; Masafumi Kitakaze; Seiji Takashima; Yasushi Sakata
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.